Biodesix Stock Analysis
BDSX Stock | USD 1.41 0.04 2.92% |
Biodesix is undervalued with Real Value of 2.06 and Target Price of 4.25. The main objective of Biodesix stock analysis is to determine its intrinsic value, which is an estimate of what Biodesix is worth, separate from its market price. There are two main types of Biodesix's stock analysis: fundamental analysis and technical analysis.
The Biodesix stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Biodesix is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Biodesix Stock trading window is adjusted to America/New York timezone.
Biodesix |
Biodesix Stock Analysis Notes
About 47.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.37. Biodesix had not issued any dividends in recent years. Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. Biodesix, Inc. was incorporated in 2005 and is headquartered in Boulder, Colorado. Biodesix operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 218 people. For more info on Biodesix please contact Scott Hutton at 303 417 0500 or go to https://www.biodesix.com.Biodesix Quarterly Total Revenue |
|
Biodesix Investment Alerts
Biodesix generated a negative expected return over the last 90 days | |
Biodesix may become a speculative penny stock | |
Biodesix has high historical volatility and very poor performance | |
Biodesix has a very high chance of going through financial distress in the upcoming years | |
Biodesix currently holds 60.69 M in liabilities with Debt to Equity (D/E) ratio of 3.2, implying the company greatly relies on financing operations through barrowing. Biodesix has a current ratio of 0.63, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Biodesix's use of debt, we should always consider it together with its cash and equity. | |
The entity reported the previous year's revenue of 49.09 M. Net Loss for the year was (52.15 M) with profit before overhead, payroll, taxes, and interest of 24.06 M. | |
Biodesix currently holds about 15.18 M in cash with (22.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
Roughly 47.0% of Biodesix shares are held by company insiders | |
Latest headline from thelincolnianonline.com: Biodesix, Inc. Shares Bought by Perkins Capital Management Inc. |
Biodesix Upcoming and Recent Events
Earnings reports are used by Biodesix to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
4th of March 2024 Upcoming Quarterly Report | View | |
9th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
4th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Biodesix Largest EPS Surprises
Earnings surprises can significantly impact Biodesix's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-08-07 | 2024-06-30 | -0.09 | -0.08 | 0.01 | 11 | ||
2023-08-07 | 2023-06-30 | -0.21 | -0.17 | 0.04 | 19 | ||
2022-08-04 | 2022-06-30 | -0.46 | -0.4 | 0.06 | 13 |
Biodesix Stock Institutional Investors
Shares | Lmr Partners Llp | 2024-06-30 | 1.6 M | Essex Investment Management Company, Llc | 2024-09-30 | 971.2 K | Wells Fargo & Co | 2024-06-30 | 931.2 K | Amh Equity Ltd | 2024-09-30 | 696.1 K | Geode Capital Management, Llc | 2024-06-30 | 533.9 K | Blackrock Inc | 2024-06-30 | 415.9 K | Perkins Capital Management Inc | 2024-06-30 | 414.8 K | Legato Capital Management Llc | 2024-06-30 | 334.3 K | State Street Corp | 2024-06-30 | 288.6 K | Telemark Asset Management, Llc | 2024-06-30 | 8.3 M | Soleus Capital Management, L.p. | 2024-06-30 | 6.1 M |
Biodesix Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 199.29 M.Biodesix Profitablity
The company has Profit Margin (PM) of (0.67) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.47) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.47.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.68) | (0.72) | |
Return On Capital Employed | (0.63) | (0.66) | |
Return On Assets | (0.53) | (0.55) | |
Return On Equity | (11.39) | (10.82) |
Management Efficiency
Biodesix has return on total asset (ROA) of (0.2279) % which means that it has lost $0.2279 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.3182) %, meaning that it created substantial loss on money invested by shareholders. Biodesix's management efficiency ratios could be used to measure how well Biodesix manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.72 in 2024. Return On Capital Employed is likely to drop to -0.66 in 2024. At this time, Biodesix's Non Currrent Assets Other are fairly stable compared to the past year. Other Assets is likely to rise to about 7.2 M in 2024, whereas Total Assets are likely to drop slightly above 86.1 M in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.06 | 0.06 | |
Tangible Book Value Per Share | (0.22) | (0.23) | |
Enterprise Value Over EBITDA | (5.18) | (5.44) | |
Price Book Value Ratio | 32.99 | 34.64 | |
Enterprise Value Multiple | (5.18) | (5.44) | |
Price Fair Value | 32.99 | 34.64 | |
Enterprise Value | 98.4 M | 93.5 M |
Leadership at Biodesix emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Operating Margin (0.47) | Profit Margin (0.67) | Beta 1.213 | Return On Assets (0.23) | Return On Equity (3.32) |
Technical Drivers
As of the 11th of November 2024, Biodesix shows the Standard Deviation of 4.19, mean deviation of 2.47, and Risk Adjusted Performance of (0.02). Biodesix technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Biodesix Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Biodesix middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Biodesix. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Biodesix Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biodesix insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biodesix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Biodesix insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Biodesix Outstanding Bonds
Biodesix issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biodesix uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biodesix bonds can be classified according to their maturity, which is the date when Biodesix has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
International Game Technology Corp BondUS460599AD57 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
MGM Resorts International Corp BondUS552953CD18 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View |
Biodesix Predictive Daily Indicators
Biodesix intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biodesix stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Biodesix Forecast Models
Biodesix's time-series forecasting models are one of many Biodesix's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biodesix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Biodesix Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Biodesix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biodesix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Biodesix. By using and applying Biodesix Stock analysis, traders can create a robust methodology for identifying Biodesix entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (1.06) | (1.12) | |
Operating Profit Margin | (0.84) | (0.88) | |
Net Loss | (1.06) | (1.12) | |
Gross Profit Margin | 0.68 | 0.69 |
Current Biodesix Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Biodesix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Biodesix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
4.25 | Strong Buy | 6 | Odds |
Most Biodesix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Biodesix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Biodesix, talking to its executives and customers, or listening to Biodesix conference calls.
Biodesix Stock Analysis Indicators
Biodesix stock analysis indicators help investors evaluate how Biodesix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Biodesix shares will generate the highest return on investment. By understating and applying Biodesix stock analysis, traders can identify Biodesix position entry and exit signals to maximize returns.
Begin Period Cash Flow | 43.2 M | |
Long Term Debt | 35.2 M | |
Common Stock Shares Outstanding | 82.1 M | |
Total Stockholder Equity | 4.6 M | |
Property Plant And Equipment Net | 29.6 M | |
Cash And Short Term Investments | 26.4 M | |
Cash | 26.4 M | |
Accounts Payable | 2.9 M | |
Net Debt | 34.3 M | |
50 Day M A | 1.6699 | |
Total Current Liabilities | 33.4 M | |
Other Operating Expenses | 90.4 M | |
Non Current Assets Total | 59.4 M | |
Non Currrent Assets Other | 6.9 M | |
Stock Based Compensation | 5.4 M |
Additional Tools for Biodesix Stock Analysis
When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.